GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cynata Therapeutics Ltd (ASX:CYP) » Definitions » Cash Received from Insurance Activities

Cynata Therapeutics (ASX:CYP) Cash Received from Insurance Activities


View and export this data going back to 2007. Start your Free Trial

What is Cynata Therapeutics Cash Received from Insurance Activities?

Cash Received from Insurance Activities only applies to insurance companies.


Cynata Therapeutics (ASX:CYP) Business Description

Industry
Traded in Other Exchanges
Address
100 Cubitt Street, Level 3, Cremorne, VIC, AUS, 3121
Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus. There are currently three active clinical trials taking place using Cymerus technology which are attempting to treat osteoarthritis, respiratory distress, and diabetic foot ulcers.